世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

感染症の世界市場 2023-2027


Global Infectious Disease Market 2023-2027

世界の感染症市場 2023-2027 Technavioは感染症市場を監視しており、2023年から2027年の間に1048億ドルの成長が見込まれ、予測期間中にCAGR 12.49%で加速しています。当レポートでは、感染症市場の全体的な分析... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年11月9日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

世界の感染症市場 2023-2027
Technavioは感染症市場を監視しており、2023年から2027年の間に1048億ドルの成長が見込まれ、予測期間中にCAGR 12.49%で加速しています。当レポートでは、感染症市場の全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。感染症市場は、感染症の有病率の増加、感染症に対する意識の高まり、強力な医薬品パイプラインなどが原動力となっています。
Technavioの感染症市場は以下のようにセグメント化されています。
製品別
- 医薬品
- ワクチン
エンドユーザー別
- 病院
- 総合診療所
- その他
地域別
- 北米
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における感染症市場の成長を促進する主な要因の1つとして、新薬の開発を挙げています。また、合併・買収の増加や新しいパターンの感染症の出現は、市場の大きな需要につながるでしょう。
Technavioは、主要パラメータの分析を通じて、複数のソースからのデータの調査、合成、集計の方法により、市場の詳細なイメージを提示します。感染症市場に関する弊社のレポートは、以下の分野を対象としています。
- 感染症市場のサイジング
- 感染症市場の予測
- 感染症市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Bio Rad Laboratories Inc.、Danaher Corp.、F. Hoffmann La Roche Ltd.、Genetic Signatures Ltd.、Grifols S.A.、Hologic Inc.など複数の主要感染症市場ベンダーについて詳細に分析しています。Grifols SA、Hologic Inc、Meridian Bioscience Inc、Meril Life Sciences Pvt. Ltd、OraSure Technologies Inc、PerkinElmer Inc、QIAGEN NV、Siemens AG、Sysmex Corp、Trinity Biotech Plc、Abbott Laboratories、Becton Dickinson and Co、 bioMerieux SA、DiaSorin SpA、 Quidel Corp、および Thermo Fisher Scientific Inc.など。また、感染症市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - [https://www.technavio.com/report/infectious-disease-market-industry-analysis](https://www.technavio.com/report/infectious-disease-market-industry-analysis?v1)
Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数のソースからのデータの研究、合成、総括の方法によって、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global infectious disease market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global infectious disease market 2017 - 2021 ($ billion)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Drugs - Market size and forecast 2022-2027
o Exhibit 34: Chart on Drugs - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Drugs - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Drugs - Year-over-year growth 2022-2027 (%)
o 6.4 Vaccines - Market size and forecast 2022-2027
o Exhibit 38: Chart on Vaccines - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Vaccines - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Vaccines - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Vaccines - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 45: Chart on Comparison by End-user
o Exhibit 46: Data Table on Comparison by End-user
o 7.3 Hospital - Market size and forecast 2022-2027
o Exhibit 47: Chart on Hospital - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Data Table on Hospital - Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Chart on Hospital - Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
o 7.4 Multispecialty clinic - Market size and forecast 2022-2027
o Exhibit 51: Chart on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Data Table on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Chart on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
o 7.5 Others - Market size and forecast 2022-2027
o Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 59: Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share by geography 2022-2027 (%)
o Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 101: Market opportunity by geography ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 108: Abbott Laboratories - Overview
o Exhibit 109: Abbott Laboratories - Business segments
o Exhibit 110: Abbott Laboratories - Key news
o Exhibit 111: Abbott Laboratories - Key offerings
o Exhibit 112: Abbott Laboratories - Segment focus
o 12.4 Becton Dickinson and Co.
o Exhibit 113: Becton Dickinson and Co. - Overview
o Exhibit 114: Becton Dickinson and Co. - Business segments
o Exhibit 115: Becton Dickinson and Co. - Key news
o Exhibit 116: Becton Dickinson and Co. - Key offerings
o Exhibit 117: Becton Dickinson and Co. - Segment focus
o 12.5 Bio Rad Laboratories Inc.
o Exhibit 118: Bio Rad Laboratories Inc. - Overview
o Exhibit 119: Bio Rad Laboratories Inc. - Business segments
o Exhibit 120: Bio Rad Laboratories Inc. - Key news
o Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 122: Bio Rad Laboratories Inc. - Segment focus
o 12.6 bioMerieux SA
o Exhibit 123: bioMerieux SA - Overview
o Exhibit 124: bioMerieux SA - Product / Service
o Exhibit 125: bioMerieux SA - Key offerings
o 12.7 Danaher Corp.
o Exhibit 126: Danaher Corp. - Overview
o Exhibit 127: Danaher Corp. - Business segments
o Exhibit 128: Danaher Corp. - Key news
o Exhibit 129: Danaher Corp. - Key offerings
o Exhibit 130: Danaher Corp. - Segment focus
o 12.8 DiaSorin SpA
o Exhibit 131: DiaSorin SpA - Overview
o Exhibit 132: DiaSorin SpA - Business segments
o Exhibit 133: DiaSorin SpA - Key news
o Exhibit 134: DiaSorin SpA - Key offerings
o Exhibit 135: DiaSorin SpA - Segment focus
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
o 12.10 Meridian Bioscience Inc.
o Exhibit 141: Meridian Bioscience Inc. - Overview
o Exhibit 142: Meridian Bioscience Inc. - Business segments
o Exhibit 143: Meridian Bioscience Inc. - Key offerings
o Exhibit 144: Meridian Bioscience Inc. - Segment focus
o 12.11 OraSure Technologies Inc.
o Exhibit 145: OraSure Technologies Inc. - Overview
o Exhibit 146: OraSure Technologies Inc. - Business segments
o Exhibit 147: OraSure Technologies Inc. - Key offerings
o Exhibit 148: OraSure Technologies Inc. - Segment focus
o 12.12 PerkinElmer Inc.
o Exhibit 149: PerkinElmer Inc. - Overview
o Exhibit 150: PerkinElmer Inc. - Business segments
o Exhibit 151: PerkinElmer Inc. - Key news
o Exhibit 152: PerkinElmer Inc. - Key offerings
o Exhibit 153: PerkinElmer Inc. - Segment focus
o 12.13 QIAGEN NV
o Exhibit 154: QIAGEN NV - Overview
o Exhibit 155: QIAGEN NV - Product / Service
o Exhibit 156: QIAGEN NV - Key news
o Exhibit 157: QIAGEN NV - Key offerings
o 12.14 Quidel Corp.
o Exhibit 158: Quidel Corp. - Overview
o Exhibit 159: Quidel Corp. - Product / Service
o Exhibit 160: Quidel Corp. - Key offerings
o 12.15 Siemens AG
o Exhibit 161: Siemens AG - Overview
o Exhibit 162: Siemens AG - Business segments
o Exhibit 163: Siemens AG - Key news
o Exhibit 164: Siemens AG - Key offerings
o Exhibit 165: Siemens AG - Segment focus
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 166: Thermo Fisher Scientific Inc. - Overview
o Exhibit 167: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 168: Thermo Fisher Scientific Inc. - Key news
o Exhibit 169: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 170: Thermo Fisher Scientific Inc. - Segment focus
o 12.17 Trinity Biotech Plc
o Exhibit 171: Trinity Biotech Plc - Overview
o Exhibit 172: Trinity Biotech Plc - Product / Service
o Exhibit 173: Trinity Biotech Plc - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 174: Inclusions checklist
o Exhibit 175: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 176: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 177: Research methodology
o Exhibit 178: Validation techniques employed for market sizing
o Exhibit 179: Information sources
o 13.5 List of abbreviations
o Exhibit 180: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global infectious disease market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Drugs - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Drugs - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Vaccines - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Vaccines - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ billion)
Exhibits43: Chart on End-user - Market share 2022-2027 (%)
Exhibits44: Data Table on End-user - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by End-user
Exhibits46: Data Table on Comparison by End-user
Exhibits47: Chart on Hospital - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on Hospital - Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits56: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by End-user ($ billion)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2022-2027 (%)
Exhibits62: Data Table on Market share by geography 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity by geography ($ billion)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Abbott Laboratories - Overview
Exhibits109: Abbott Laboratories - Business segments
Exhibits110: Abbott Laboratories - Key news
Exhibits111: Abbott Laboratories - Key offerings
Exhibits112: Abbott Laboratories - Segment focus
Exhibits113: Becton Dickinson and Co. - Overview
Exhibits114: Becton Dickinson and Co. - Business segments
Exhibits115: Becton Dickinson and Co. - Key news
Exhibits116: Becton Dickinson and Co. - Key offerings
Exhibits117: Becton Dickinson and Co. - Segment focus
Exhibits118: Bio Rad Laboratories Inc. - Overview
Exhibits119: Bio Rad Laboratories Inc. - Business segments
Exhibits120: Bio Rad Laboratories Inc. - Key news
Exhibits121: Bio Rad Laboratories Inc. - Key offerings
Exhibits122: Bio Rad Laboratories Inc. - Segment focus
Exhibits123: bioMerieux SA - Overview
Exhibits124: bioMerieux SA - Product / Service
Exhibits125: bioMerieux SA - Key offerings
Exhibits126: Danaher Corp. - Overview
Exhibits127: Danaher Corp. - Business segments
Exhibits128: Danaher Corp. - Key news
Exhibits129: Danaher Corp. - Key offerings
Exhibits130: Danaher Corp. - Segment focus
Exhibits131: DiaSorin SpA - Overview
Exhibits132: DiaSorin SpA - Business segments
Exhibits133: DiaSorin SpA - Key news
Exhibits134: DiaSorin SpA - Key offerings
Exhibits135: DiaSorin SpA - Segment focus
Exhibits136: F. Hoffmann La Roche Ltd. - Overview
Exhibits137: F. Hoffmann La Roche Ltd. - Business segments
Exhibits138: F. Hoffmann La Roche Ltd. - Key news
Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits141: Meridian Bioscience Inc. - Overview
Exhibits142: Meridian Bioscience Inc. - Business segments
Exhibits143: Meridian Bioscience Inc. - Key offerings
Exhibits144: Meridian Bioscience Inc. - Segment focus
Exhibits145: OraSure Technologies Inc. - Overview
Exhibits146: OraSure Technologies Inc. - Business segments
Exhibits147: OraSure Technologies Inc. - Key offerings
Exhibits148: OraSure Technologies Inc. - Segment focus
Exhibits149: PerkinElmer Inc. - Overview
Exhibits150: PerkinElmer Inc. - Business segments
Exhibits151: PerkinElmer Inc. - Key news
Exhibits152: PerkinElmer Inc. - Key offerings
Exhibits153: PerkinElmer Inc. - Segment focus
Exhibits154: QIAGEN NV - Overview
Exhibits155: QIAGEN NV - Product / Service
Exhibits156: QIAGEN NV - Key news
Exhibits157: QIAGEN NV - Key offerings
Exhibits158: Quidel Corp. - Overview
Exhibits159: Quidel Corp. - Product / Service
Exhibits160: Quidel Corp. - Key offerings
Exhibits161: Siemens AG - Overview
Exhibits162: Siemens AG - Business segments
Exhibits163: Siemens AG - Key news
Exhibits164: Siemens AG - Key offerings
Exhibits165: Siemens AG - Segment focus
Exhibits166: Thermo Fisher Scientific Inc. - Overview
Exhibits167: Thermo Fisher Scientific Inc. - Business segments
Exhibits168: Thermo Fisher Scientific Inc. - Key news
Exhibits169: Thermo Fisher Scientific Inc. - Key offerings
Exhibits170: Thermo Fisher Scientific Inc. - Segment focus
Exhibits171: Trinity Biotech Plc - Overview
Exhibits172: Trinity Biotech Plc - Product / Service
Exhibits173: Trinity Biotech Plc - Key offerings
Exhibits174: Inclusions checklist
Exhibits175: Exclusions checklist
Exhibits176: Currency conversion rates for US$
Exhibits177: Research methodology
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Information sources
Exhibits180: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Infectious Disease Market 2023-2027
Technavio has been monitoring the infectious disease market and it is poised to grow by $104.81 bn during 2023-2027, accelerating at a CAGR of 12.49% during the forecast period. Our report on the infectious disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of infectious diseases, growing awareness of infectious diseases, and a strong drug pipeline.
Technavio's infectious disease market is segmented as below:
By Product
• Drugs
• Vaccines
By End-user
• Hospital
• Multispecialty clinic
• Others
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the development of novel drugs as one of the prime reasons driving the infectious disease market growth during the next few years. Also, increasing mergers and acquisitions and the emergence of new patterns of infectious diseases will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on the infectious disease market covers the following areas:
• Infectious disease market sizing
• Infectious disease market forecast
• Infectious disease market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading infectious disease market vendors that include Bio Rad Laboratories Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Trinity Biotech Plc, Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, Quidel Corp., and Thermo Fisher Scientific Inc. Also, the infectious disease market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - [https://www.technavio.com/report/infectious-disease-market-industry-analysis](https://www.technavio.com/report/infectious-disease-market-industry-analysis?v1)
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global infectious disease market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global infectious disease market 2017 - 2021 ($ billion)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Drugs - Market size and forecast 2022-2027
o Exhibit 34: Chart on Drugs - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Drugs - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Drugs - Year-over-year growth 2022-2027 (%)
o 6.4 Vaccines - Market size and forecast 2022-2027
o Exhibit 38: Chart on Vaccines - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Vaccines - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Vaccines - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Vaccines - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 45: Chart on Comparison by End-user
o Exhibit 46: Data Table on Comparison by End-user
o 7.3 Hospital - Market size and forecast 2022-2027
o Exhibit 47: Chart on Hospital - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Data Table on Hospital - Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Chart on Hospital - Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
o 7.4 Multispecialty clinic - Market size and forecast 2022-2027
o Exhibit 51: Chart on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Data Table on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Chart on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
o 7.5 Others - Market size and forecast 2022-2027
o Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 59: Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share by geography 2022-2027 (%)
o Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 101: Market opportunity by geography ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 108: Abbott Laboratories - Overview
o Exhibit 109: Abbott Laboratories - Business segments
o Exhibit 110: Abbott Laboratories - Key news
o Exhibit 111: Abbott Laboratories - Key offerings
o Exhibit 112: Abbott Laboratories - Segment focus
o 12.4 Becton Dickinson and Co.
o Exhibit 113: Becton Dickinson and Co. - Overview
o Exhibit 114: Becton Dickinson and Co. - Business segments
o Exhibit 115: Becton Dickinson and Co. - Key news
o Exhibit 116: Becton Dickinson and Co. - Key offerings
o Exhibit 117: Becton Dickinson and Co. - Segment focus
o 12.5 Bio Rad Laboratories Inc.
o Exhibit 118: Bio Rad Laboratories Inc. - Overview
o Exhibit 119: Bio Rad Laboratories Inc. - Business segments
o Exhibit 120: Bio Rad Laboratories Inc. - Key news
o Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 122: Bio Rad Laboratories Inc. - Segment focus
o 12.6 bioMerieux SA
o Exhibit 123: bioMerieux SA - Overview
o Exhibit 124: bioMerieux SA - Product / Service
o Exhibit 125: bioMerieux SA - Key offerings
o 12.7 Danaher Corp.
o Exhibit 126: Danaher Corp. - Overview
o Exhibit 127: Danaher Corp. - Business segments
o Exhibit 128: Danaher Corp. - Key news
o Exhibit 129: Danaher Corp. - Key offerings
o Exhibit 130: Danaher Corp. - Segment focus
o 12.8 DiaSorin SpA
o Exhibit 131: DiaSorin SpA - Overview
o Exhibit 132: DiaSorin SpA - Business segments
o Exhibit 133: DiaSorin SpA - Key news
o Exhibit 134: DiaSorin SpA - Key offerings
o Exhibit 135: DiaSorin SpA - Segment focus
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
o 12.10 Meridian Bioscience Inc.
o Exhibit 141: Meridian Bioscience Inc. - Overview
o Exhibit 142: Meridian Bioscience Inc. - Business segments
o Exhibit 143: Meridian Bioscience Inc. - Key offerings
o Exhibit 144: Meridian Bioscience Inc. - Segment focus
o 12.11 OraSure Technologies Inc.
o Exhibit 145: OraSure Technologies Inc. - Overview
o Exhibit 146: OraSure Technologies Inc. - Business segments
o Exhibit 147: OraSure Technologies Inc. - Key offerings
o Exhibit 148: OraSure Technologies Inc. - Segment focus
o 12.12 PerkinElmer Inc.
o Exhibit 149: PerkinElmer Inc. - Overview
o Exhibit 150: PerkinElmer Inc. - Business segments
o Exhibit 151: PerkinElmer Inc. - Key news
o Exhibit 152: PerkinElmer Inc. - Key offerings
o Exhibit 153: PerkinElmer Inc. - Segment focus
o 12.13 QIAGEN NV
o Exhibit 154: QIAGEN NV - Overview
o Exhibit 155: QIAGEN NV - Product / Service
o Exhibit 156: QIAGEN NV - Key news
o Exhibit 157: QIAGEN NV - Key offerings
o 12.14 Quidel Corp.
o Exhibit 158: Quidel Corp. - Overview
o Exhibit 159: Quidel Corp. - Product / Service
o Exhibit 160: Quidel Corp. - Key offerings
o 12.15 Siemens AG
o Exhibit 161: Siemens AG - Overview
o Exhibit 162: Siemens AG - Business segments
o Exhibit 163: Siemens AG - Key news
o Exhibit 164: Siemens AG - Key offerings
o Exhibit 165: Siemens AG - Segment focus
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 166: Thermo Fisher Scientific Inc. - Overview
o Exhibit 167: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 168: Thermo Fisher Scientific Inc. - Key news
o Exhibit 169: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 170: Thermo Fisher Scientific Inc. - Segment focus
o 12.17 Trinity Biotech Plc
o Exhibit 171: Trinity Biotech Plc - Overview
o Exhibit 172: Trinity Biotech Plc - Product / Service
o Exhibit 173: Trinity Biotech Plc - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 174: Inclusions checklist
o Exhibit 175: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 176: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 177: Research methodology
o Exhibit 178: Validation techniques employed for market sizing
o Exhibit 179: Information sources
o 13.5 List of abbreviations
o Exhibit 180: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global infectious disease market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Drugs - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Drugs - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Vaccines - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Vaccines - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ billion)
Exhibits43: Chart on End-user - Market share 2022-2027 (%)
Exhibits44: Data Table on End-user - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by End-user
Exhibits46: Data Table on Comparison by End-user
Exhibits47: Chart on Hospital - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on Hospital - Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits56: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by End-user ($ billion)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2022-2027 (%)
Exhibits62: Data Table on Market share by geography 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity by geography ($ billion)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Abbott Laboratories - Overview
Exhibits109: Abbott Laboratories - Business segments
Exhibits110: Abbott Laboratories - Key news
Exhibits111: Abbott Laboratories - Key offerings
Exhibits112: Abbott Laboratories - Segment focus
Exhibits113: Becton Dickinson and Co. - Overview
Exhibits114: Becton Dickinson and Co. - Business segments
Exhibits115: Becton Dickinson and Co. - Key news
Exhibits116: Becton Dickinson and Co. - Key offerings
Exhibits117: Becton Dickinson and Co. - Segment focus
Exhibits118: Bio Rad Laboratories Inc. - Overview
Exhibits119: Bio Rad Laboratories Inc. - Business segments
Exhibits120: Bio Rad Laboratories Inc. - Key news
Exhibits121: Bio Rad Laboratories Inc. - Key offerings
Exhibits122: Bio Rad Laboratories Inc. - Segment focus
Exhibits123: bioMerieux SA - Overview
Exhibits124: bioMerieux SA - Product / Service
Exhibits125: bioMerieux SA - Key offerings
Exhibits126: Danaher Corp. - Overview
Exhibits127: Danaher Corp. - Business segments
Exhibits128: Danaher Corp. - Key news
Exhibits129: Danaher Corp. - Key offerings
Exhibits130: Danaher Corp. - Segment focus
Exhibits131: DiaSorin SpA - Overview
Exhibits132: DiaSorin SpA - Business segments
Exhibits133: DiaSorin SpA - Key news
Exhibits134: DiaSorin SpA - Key offerings
Exhibits135: DiaSorin SpA - Segment focus
Exhibits136: F. Hoffmann La Roche Ltd. - Overview
Exhibits137: F. Hoffmann La Roche Ltd. - Business segments
Exhibits138: F. Hoffmann La Roche Ltd. - Key news
Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits141: Meridian Bioscience Inc. - Overview
Exhibits142: Meridian Bioscience Inc. - Business segments
Exhibits143: Meridian Bioscience Inc. - Key offerings
Exhibits144: Meridian Bioscience Inc. - Segment focus
Exhibits145: OraSure Technologies Inc. - Overview
Exhibits146: OraSure Technologies Inc. - Business segments
Exhibits147: OraSure Technologies Inc. - Key offerings
Exhibits148: OraSure Technologies Inc. - Segment focus
Exhibits149: PerkinElmer Inc. - Overview
Exhibits150: PerkinElmer Inc. - Business segments
Exhibits151: PerkinElmer Inc. - Key news
Exhibits152: PerkinElmer Inc. - Key offerings
Exhibits153: PerkinElmer Inc. - Segment focus
Exhibits154: QIAGEN NV - Overview
Exhibits155: QIAGEN NV - Product / Service
Exhibits156: QIAGEN NV - Key news
Exhibits157: QIAGEN NV - Key offerings
Exhibits158: Quidel Corp. - Overview
Exhibits159: Quidel Corp. - Product / Service
Exhibits160: Quidel Corp. - Key offerings
Exhibits161: Siemens AG - Overview
Exhibits162: Siemens AG - Business segments
Exhibits163: Siemens AG - Key news
Exhibits164: Siemens AG - Key offerings
Exhibits165: Siemens AG - Segment focus
Exhibits166: Thermo Fisher Scientific Inc. - Overview
Exhibits167: Thermo Fisher Scientific Inc. - Business segments
Exhibits168: Thermo Fisher Scientific Inc. - Key news
Exhibits169: Thermo Fisher Scientific Inc. - Key offerings
Exhibits170: Thermo Fisher Scientific Inc. - Segment focus
Exhibits171: Trinity Biotech Plc - Overview
Exhibits172: Trinity Biotech Plc - Product / Service
Exhibits173: Trinity Biotech Plc - Key offerings
Exhibits174: Inclusions checklist
Exhibits175: Exclusions checklist
Exhibits176: Currency conversion rates for US$
Exhibits177: Research methodology
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Information sources
Exhibits180: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

TechNavio社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD(infectious disease)の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る